𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Total parenteral nutrition as the sole therapy in Crohn's disease—a prospective study

✍ Scribed by J. M. Müller; H. W. Keller; Heide Erasmi; H. Pichlmaier

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
481 KB
Volume
70
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impacts of long-term enteral nutrition o
Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study
✍ Takayuki Yamamoto; Maki Nakahigashi; Abbi R. Saniabadi; Takashi Iwata; Yasuki Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Background: Long-term enteral nutrition may maintain clinical and endoscopic remission in patients with crohn's disease (cd). the aim of this prospective study was to investigate the impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal tissue cytokines

A double-blind, placebo-controlled study
A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
✍ Barry J. Snow; Fiona L. Rolfe; Michelle M. Lockhart; Christopher M. Frampton; Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract Multiple lines of evidence point to mitochondrial oxidative stress as a potential pathogenic cause for Parkinson's disease (PD). MitoQ is a powerful mitochondrial antioxidant. It is absorbed orally and concentrates within mitochondria where it has been shown to protect against oxidative

Does clinical response correlate with mu
Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy
✍ Alkiviadis Efthymiou; Nikos Viazis; Gerassimos Mantzaris; Nikos Papadimitriou; D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Background: There are no studies assessing mucosal healing of the small bowel in patients with Crohn's disease (CD). Our aim was to assess the correlation between clinical response and mucosal healing of the small bowel using wireless capsule endoscopy (WCE). ## Methods: This was a prospecti

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
✍ C. Warren Olanow; Robert A. Hauser; Joseph Jankovic; William Langston; Anthony L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

## Abstract A neuroprotective therapy is the single most important unmet medical need in Parkinson's disease. Several promising agents in the laboratory have been tested in the clinic, but none has been established in clinical trials to have a disease modifying effect despite positive results becau

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to